INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVAPRNewsWire • Thursday
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?Zacks Investment Research • Tuesday
DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health RisksPRNewsWire • Tuesday
DaVita HealthCare (DVA) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks Investment Research • 10/23/26
DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney CarePRNewsWire • 10/15/26
Here's Why You Should Retain DaVita Stock in Your Portfolio for NowZacks Investment Research • 10/09/26
DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare EarlyPRNewsWire • 10/08/26
3 Berkshire Hathaway Holdings to Buy While They Sit at Least 15% Below Their HighsThe Motley Fool • 10/06/26
This Warren Buffett Stock Is Up 58%. History Says This Is What Happens Next.The Motley Fool • 09/29/26
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 09/24/26
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for InvestorsZacks Investment Research • 09/16/26
Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report?Zacks Investment Research • 09/03/26